Catalyst Biosciences Announces Chief Financial Officer Transition

SOUTH SAN FRANCISCO, Calif., Oct. 13, 2021 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that its chief financial officer, Clinton Musil, has resigned for personal reasons effective October 29, 2021. Seline Miller, the Company’s controller, has been promoted to senior vice president, finance and will serve as...

Click to view original post